Our digital cognitive
screening unlocks
timely access to care meaningful intervention more good years together

PROVIDERS

Screen with confidence in a fraction of the time

A patient-administered test, complete in 3 minutes

Learn more

Payers

Better ROI starts with better screening

Go from underdiagnosis to early diagnosis—and improved outcomes

Learn more

Our advantages

Distinguishes cognitive impairment from normal aging

Treat with confidence

Outperforms the "gold standard"

FDA-registered device with groundbreaking sensitivity and specificity

Culturally agnostic

Designed with inclusive symbols and translated into multiple languages

Easy to track over time

Instant, objective score is a single data point

Customized to your clinical workflow

Integrates into your EHR

Underdiagnosis is a big problem

Almost 6 in 10 people with probable dementia are undiagnosed

SOURCE: Journal of General Internal Medicine

Identify who needs more care

60% of PCPs say they don’t have enough time to screen

SOURCE: Alzheimer's Association

$7.9 trillion would be saved by early diagnosis

SOURCE: Alzheimer's Association

Company News

August 16, 2023

Neurotrack named to the Norrsken Impact/100

August 16, 2023

Neurotrack named to the Norrsken Impact/100

An annual list of the world's most promising impact startups

July 6, 2023

An Rx for our Dx: Leqembi is approved!

July 6, 2023

An Rx for our Dx: Leqembi is approved!

Answers to 6 common questions about the disease modifying drug

February 8, 2023

Pitch Perfect: Neurotrack earns top prize from Alzheimer’s Association

February 8, 2023

Pitch Perfect: Neurotrack earns top prize from Alzheimer’s Association

Recognized for clinically-validated digital tests and cognitive health program

This entrepreneur aims to make cognitive screening as easy as checking your pulse.

- Alex Knapp, Forbes Staff

Our digital cognitive screening unlocks timely access to care meaningful intervention more good years together

PROVIDERS

Screen with confidence in a fraction of the time

Payers

Better ROI starts with better screening

Our advantages

Distinguishes cognitive impairment from normal aging

Outperforms the "gold standard"

Culturally agnostic

Easy to track over time

Customized to your clinical workflow

Under­diagnosis is a big problem

Almost 6 in 10 people with probable dementia are undiagnosed

Identify who needs more care

60% of PCPs say they don’t have enough time to screen

$7.9 trillion would be saved by early diagnosis

Company News

August 16, 2023

Neurotrack named to the Norrsken Impact/100

August 16, 2023

Neurotrack named to the Norrsken Impact/100

An annual list of the world's most promising impact startups

July 6, 2023

An Rx for our Dx: Leqembi is approved!

July 6, 2023

An Rx for our Dx: Leqembi is approved!

Answers to 6 common questions about the disease modifying drug

February 8, 2023

Pitch Perfect: Neurotrack earns top prize from Alzheimer’s Association

February 8, 2023

Pitch Perfect: Neurotrack earns top prize from Alzheimer’s Association

Recognized for clinically-validated digital tests and cognitive health program

As seen in

This entrepreneur aims to make cognitive screening as easy as checking your pulse.

Our Partners

Discover an efficient, effective way to screen cognition

Our digital cognitive
screening unlocks
timely access to care meaningful intervention more good years together

Underdiagnosis is a big problem